Immune checkpoint inhibitor re-challenge in patients with advanced non-small cell lung cancer

Abstract

Our study shows the effectiveness of re-challenge of immune checkpoint inhibitors in a subset of non-small cell lung cancer patients. Re-challenge might become one of treatment option for advanced non-small cell lung cancer.